Literature DB >> 3337337

Prognostic implications of the tall cell variant of papillary thyroid carcinoma.

T L Johnson1, R V Lloyd, N W Thompson, W H Beierwaltes, J C Sisson.   

Abstract

The tall cell variant (TCV) of papillary thyroid carcinoma, characterized by a population of tall columnar cells with a height at least twice the width, was analyzed in 12 patients and compared to tumors from 12 patients with the usual type of papillary thyroid carcinoma (UPTC) matched for age, sex, and date of diagnosis to determine if tall cell histology had prognostic significance. Patients with TCV had significantly higher incidences of extrathyroidal disease, recurrent disease, and metastases compared to patients with UPTC. TCV patients also died of their tumors more frequently than UPTC patients (3/12 versus 0/12). There was no significant difference in tumor size or in the incidence of cervical lymph node involvement between the patient groups. These results show that TCV of papillary thyroid carcinoma has a more aggressive clinical course and a worse prognosis than UPTC in patient groups with similar age and sex distribution, length of follow-up, and tumor size.

Entities:  

Mesh:

Year:  1988        PMID: 3337337     DOI: 10.1097/00000478-198801000-00003

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  38 in total

Review 1.  Thyroid cancer surgery.

Authors:  R Udelsman
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

Review 2.  Unusual types of thyroid cancer.

Authors:  K B Ain
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

3.  The tall cell variant of papillary thyroid carcinoma: clinical and pathological features and outcomes.

Authors:  C Regalbuto; P Malandrino; F Frasca; G Pellegriti; R Le Moli; R Vigneri; V Pezzino
Journal:  J Endocrinol Invest       Date:  2012-07-09       Impact factor: 4.256

Review 4.  Papillary carcinoma tall cell variant (TCV): a review.

Authors:  Virginia A LiVolsi
Journal:  Endocr Pathol       Date:  2010-03       Impact factor: 3.943

Review 5.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

6.  NM23 protein in neoplastic and nonneoplastic thyroid tissues.

Authors:  P Bertheau; A De La Rosa; P S Steeg; M J Merino
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

7.  Prognostic outcomes of tall cell variant papillary thyroid cancer: a meta-analysis.

Authors:  Scharukh Jalisi; Tiffiny Ainsworth; Michael Lavalley
Journal:  J Thyroid Res       Date:  2010-07-26

8.  Papillary carcinoma of the thyroid in Japan: subclassification of common type and identification of low risk group.

Authors:  K Kakudo; W Tang; Y Ito; I Mori; Y Nakamura; A Miyauchi
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

9.  Papillary thyroid carcinoma with fibromatosis-like stroma: a report of two cases.

Authors:  Michiko Inaba; Shinobu Umemura; Haruhiro Satoh; Yasuko Ichikawa; Yosifumi Abe; Kiyoshi Kirokawa; Hideto Sakai; R Yoshiyuki Osamura
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

10.  Hurthle cell carcinoma arising from thyroid papillary carcinoma.

Authors:  L Jonathan Zwi; Virginia A LiVolsi
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.